Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.
about
Patient selection in heart failure with preserved ejection fraction clinical trialsDisease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial.Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer's disease.Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure.Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failureA studentized permutation test for three-arm trials in the 'gold standard' design.Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal <70 mg/dL: a real-life cohort in a developing country.Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model.Learning from recent trials and shaping the future of acute heart failure trials.Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.Win Ratio -An Intuitive and Easy-To-Interpret Composite Outcome in Medical StudiesAdvances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.Atrial fibrillation and cognitive function in patients with heart failure: a systematic review and meta-analysis.Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components.Analysing adverse events by time-to-event models: the CLEOPATRA study.Burden of Coronary Heart Disease Rehospitalizations Following Acute Myocardial Infarction in Older Adults.Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials.Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure.Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure.Cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions.The stratified win ratio.Design and analysis of three-arm trials with negative binomially distributed endpoints.Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.Publishing in a heart failure journal-where lies the scientific interest?A joint frailty model provides for risk stratification of HIV-infected patients based on unobserved heterogeneity.Disease Management Plus Recommended Care versus Recommended Care Alone for Ambulatory COPD Patients.
P2860
Q27015845-FDD1E20E-7847-4AAC-8E63-0CE297FBB617Q30847356-B8AB4DE8-FECD-4D10-AC9D-10B9AE279FFCQ30937478-ADEE83A3-BB02-48C6-9C0A-F42FBC4F498CQ35020050-0B524757-9B08-49DE-8D9A-4274A1719DBAQ35393885-7D5592B5-D087-496B-9E04-1F77F507A319Q36196674-0B5434B3-E95C-4C05-9E33-A2FD62E78C35Q36354815-1F4E6D5B-D24A-4284-B9D4-D5E1388960ECQ36658187-AC705DDF-7A22-43AA-95A4-82B7D607A336Q37248454-FEDE177D-F976-4725-900B-2A7BD9705E70Q37531278-D3D09483-073B-4A7B-9F67-4FBAD3A35D17Q37710165-33AFAECF-5583-45DC-8C27-1787ABD4678AQ38528288-8F3D824E-7141-400F-9855-828AE53ED239Q38592514-4294E9B5-1685-4899-8AAF-5FAA7E12AAF1Q38645812-669B7881-F522-4709-AF1C-695932D06D7BQ38764956-86E81C3D-7140-4B59-AA06-83A9AAC99599Q38806549-CCC9A6E2-B8CC-464D-936E-AAD82BA69A27Q38955252-1ECB682E-6056-4838-8ACB-E17B0AA57399Q39008820-D07507D7-B061-4975-A082-1CEBC1200C37Q39146653-63DD54E1-5F5C-4201-BB2A-509FDA8CD76FQ39531417-20FC626A-40E4-4C83-BE59-FB29E8D40BCDQ39676402-45CB6EB2-C60B-479D-B2D4-4418C8BDCE9CQ39981333-EE3E187D-2270-4F38-A808-8677FB8F657FQ40066805-B1C30A48-A22C-4379-9776-8C63A47950E6Q40135493-F5DEB11F-BC78-432B-9BD9-FB584E65548AQ41381124-095B6A63-C89A-4102-9268-97FF7104B7D8Q41628214-37EE59AC-118C-443E-8711-6C586B9B71EAQ44995769-CFD4FCCC-2137-47BE-9002-04B0BE3015D8Q47417660-D05B481D-5301-4AA2-AB4E-E55CFD8F135FQ47613237-0DA3DD97-4BDA-4C4A-917B-3BFBFE3850C1Q47771118-76989B6E-6093-43E1-A0C1-914428B4E5CAQ49931164-31B0B9F7-E407-4642-9ED4-D9AE6C3ACF36Q50048824-6D40C389-06A5-4ABE-8876-516305833EEAQ50060452-29048CF7-D16F-4C06-ACCE-76162B4D0845Q52679681-F4728939-1EB7-480C-AC7A-6056D709176E
P2860
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@ast
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@en
type
label
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@ast
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@en
prefLabel
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@ast
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@en
P2093
P2860
P50
P921
P356
P1476
Analysing recurrent hospitaliz ...... pplication to CHARM-Preserved.
@en
P2093
Eric L Michelson
Jan Östergren
Jennifer K Rogers
John J V McMurray
Marc A Pfeffer
Scott D Solomon
Stuart J Pocock
P2860
P356
10.1002/EJHF.29
P577
2013-12-18T00:00:00Z